BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 17456054)

  • 1. Identification of novel molecular prognostic markers for paediatric T-cell acute lymphoblastic leukaemia.
    Gottardo NG; Hoffmann K; Beesley AH; Freitas JR; Firth MJ; Perera KU; de Klerk NH; Baker DL; Kees UR
    Br J Haematol; 2007 May; 137(4):319-28. PubMed ID: 17456054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
    Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
    Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The gene expression signature of relapse in paediatric acute lymphoblastic leukaemia: implications for mechanisms of therapy failure.
    Beesley AH; Cummings AJ; Freitas JR; Hoffmann K; Firth MJ; Ford J; de Klerk NH; Kees UR
    Br J Haematol; 2005 Nov; 131(4):447-56. PubMed ID: 16281934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of relapse in paediatric pre-B acute lymphoblastic leukaemia using a three-gene risk index.
    Hoffmann K; Firth MJ; Beesley AH; Freitas JR; Ford J; Senanayake S; de Klerk NH; Baker DL; Kees UR
    Br J Haematol; 2008 Mar; 140(6):656-64. PubMed ID: 18302714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of late cell cycle genes and an increased proliferative capacity characterize very early relapse of childhood acute lymphoblastic leukemia.
    Kirschner-Schwabe R; Lottaz C; Tödling J; Rhein P; Karawajew L; Eckert C; von Stackelberg A; Ungethüm U; Kostka D; Kulozik AE; Ludwig WD; Henze G; Spang R; Hagemeier C; Seeger K
    Clin Cancer Res; 2006 Aug; 12(15):4553-61. PubMed ID: 16899601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of CpG island methylator phenotype defines a clinical subtype of T-cell acute lymphoblastic leukemia associated with good prognosis.
    Roman-Gomez J; Jimenez-Velasco A; Agirre X; Prosper F; Heiniger A; Torres A
    J Clin Oncol; 2005 Oct; 23(28):7043-9. PubMed ID: 16192589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relationship between expression of GYPC and TRIP3 genes and prognosis of acute lymphoblastic leukemia in children].
    Zhang JB; Li XH; Ning F; Guo XS
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jan; 11(1):29-32. PubMed ID: 19149918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential gene expression patterns and interaction networks in BCR-ABL-positive and -negative adult acute lymphoblastic leukemias.
    Juric D; Lacayo NJ; Ramsey MC; Racevskis J; Wiernik PH; Rowe JM; Goldstone AH; O'Dwyer PJ; Paietta E; Sikic BI
    J Clin Oncol; 2007 Apr; 25(11):1341-9. PubMed ID: 17312329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profiling reveals intrinsic differences between T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma.
    Raetz EA; Perkins SL; Bhojwani D; Smock K; Philip M; Carroll WL; Min DJ
    Pediatr Blood Cancer; 2006 Aug; 47(2):130-40. PubMed ID: 16358311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low mRNA expression of the apoptosis-related genes CASP3, CASP8, and FAS is associated with low induction treatment response in childhood acute lymphoblastic leukemia (ALL).
    Mata JF; Silveira VS; Mateo EC; Cortez MA; Queiroz RG; Yunes JA; Lee ML; Toledo SR; Petrilli AS; Brandalise SR; Tone LG; Scrideli CA
    Pediatr Blood Cancer; 2010 Jul; 55(1):100-7. PubMed ID: 20232432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of prognosis markers in pediatric high-risk acute lymphoblastic leukemia.
    Al-Lamki Z; Wali YA; Wasifuddin SM; Zachariah M; Al-Mjeni R; Li C; Muralitharan S; Al-Kharusi K; Gunaratne P; Peterson L; Gibbs R; Gingras MC; Margolin JF
    Pediatr Hematol Oncol; 2005; 22(7):629-43. PubMed ID: 16166056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group.
    Bader P; Kreyenberg H; Henze GH; Eckert C; Reising M; Willasch A; Barth A; Borkhardt A; Peters C; Handgretinger R; Sykora KW; Holter W; Kabisch H; Klingebiel T; von Stackelberg A;
    J Clin Oncol; 2009 Jan; 27(3):377-84. PubMed ID: 19064980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aven overexpression: association with poor prognosis in childhood acute lymphoblastic leukemia.
    Choi J; Hwang YK; Sung KW; Kim DH; Yoo KH; Jung HL; Koo HH
    Leuk Res; 2006 Aug; 30(8):1019-25. PubMed ID: 16388850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and prognostic significance of the apoptotic genes BCL2L13, Livin, and CASP8AP2 in childhood acute lymphoblastic leukemia.
    Yang YL; Lin SR; Chen JS; Lin SW; Yu SL; Chen HY; Yen CT; Lin CY; Lin JF; Lin KH; Jou ST; Hu CY; Chang SK; Lu MY; Chang HH; Chang WH; Lin KS; Lin DT
    Leuk Res; 2010 Jan; 34(1):18-23. PubMed ID: 20109966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine/cytokine receptor gene expression in childhood acute lymphoblastic leukemia: correlation of expression and clinical outcome at first disease recurrence.
    Wu S; Gessner R; von Stackelberg A; Kirchner R; Henze G; Seeger K
    Cancer; 2005 Mar; 103(5):1054-63. PubMed ID: 15651075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High nerve growth factor receptor (p75NTR) expression is a favourable prognostic factor in paediatric B cell precursor-acute lymphoblastic leukaemia.
    Troeger A; Gudowius S; Escherich G; den Boer ML; Glouchkova L; Ackermann B; Meisel R; Laws HJ; Groeger M; Wessalowski R; Willers R; Harbott J; Pieters R; Goebel U; Janka-Schaub GE; Hanenberg H; Dilloo D
    Br J Haematol; 2007 Nov; 139(3):450-7. PubMed ID: 17910636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of acute leukemias by use of microarray technology.
    Kohlmann A; Schoch C; Schnittger S; Dugas M; Hiddemann W; Kern W; Haferlach T
    Genes Chromosomes Cancer; 2003 Aug; 37(4):396-405. PubMed ID: 12800151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report.
    Martinelli G; Iacobucci I; Storlazzi CT; Vignetti M; Paoloni F; Cilloni D; Soverini S; Vitale A; Chiaretti S; Cimino G; Papayannidis C; Paolini S; Elia L; Fazi P; Meloni G; Amadori S; Saglio G; Pane F; Baccarani M; Foà R
    J Clin Oncol; 2009 Nov; 27(31):5202-7. PubMed ID: 19770381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetics of paediatric and adolescent acute lymphoblastic leukaemia.
    Harrison CJ
    Br J Haematol; 2009 Jan; 144(2):147-56. PubMed ID: 19006567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High level expression of N-acetylgluosamine-6-O-sulfotransferase is characteristic of a subgroup of paediatric precursor-B acute lymphoblastic leukaemia.
    Timson G; Banavali S; Gutierrez MI; Magrath I; Bhatia KG; Goyns MH
    Cancer Lett; 2006 Oct; 242(2):239-44. PubMed ID: 16386360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.